| Leslie Ann Gibson, CNM, FNP-BC | |
|
1010 Rio Grande Ave, Montrose, CO 81401-4831 | |
| (970) 497-3333 | |
| (855) 299-7837 |
| Full Name | Leslie Ann Gibson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 12 Years |
| Location | 1010 Rio Grande Ave, Montrose, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235470840 | NPI | - | NPPES |
| 16285832 | Medicaid | CO | |
| APN.0993153-NP | Other | CO | STATE LICENSE |
| 990644 | Other | CO | STATE LICENSE |
| 118859 | Other | CO | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | APN.0993153-NP (Colorado) | Secondary |
| 367A00000X | Advanced Practice Midwife | 990644 (Colorado) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scl Health Medical Group - Grand Junction Llc | 3779707856 | 207 |
News Archive
The disease course of COVID-19 is diverse, ranging from asymptomatic to fatal respiratory failure. Scientists have been working to uncover the immunological reasons behind this heterogeneity. A recent study on B cells, published on the preprint server medRxiv in April 2020, shows that extrafollicular B cells could be a marker of severe infection in the early stages, predicting the need for earlier immunomodulatory therapy.
Silence Therapeutics plc announces the issuance of United States patent 7,893,245, titled "Interfering RNA Molecules," by the United States Patent and Trademark Office.
"Twenty-eight years since the first HIV/AIDS case was reported in Kenya, organizations are proposing a new model to fight the epidemic," Sabahi reports. "The model, called 'SAVE,' an acronym for 'Safer practices, Access to treatment, Voluntary counseling and testing, and Empowerment,' hopes to improve the traditional ABC model, which focused on 'Abstinence, Being faithful, and using Condoms,'" the news service adds.
Type 1 diabetes mellitus (T1DM) affects thousands of children, and causes high sugar levels because of low insulin production. In places with good access to medical care, blood glucose is first measured by capillary blood testing or continuous monitoring. Insulin is given as required by subcutaneous injection or insulin pump.
Kapa Biosystems and VWR International, LLC announced today that they have entered into a non-exclusive North American distribution agreement for Kapa Biosystems' line of next-generation PCR reagents.
› Verified 2 days ago
| Entity Name | St Marys Hospital And Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275714081 PECOS PAC ID: 1557267069 Enrollment ID: O20031218000149 |
News Archive
The disease course of COVID-19 is diverse, ranging from asymptomatic to fatal respiratory failure. Scientists have been working to uncover the immunological reasons behind this heterogeneity. A recent study on B cells, published on the preprint server medRxiv in April 2020, shows that extrafollicular B cells could be a marker of severe infection in the early stages, predicting the need for earlier immunomodulatory therapy.
Silence Therapeutics plc announces the issuance of United States patent 7,893,245, titled "Interfering RNA Molecules," by the United States Patent and Trademark Office.
"Twenty-eight years since the first HIV/AIDS case was reported in Kenya, organizations are proposing a new model to fight the epidemic," Sabahi reports. "The model, called 'SAVE,' an acronym for 'Safer practices, Access to treatment, Voluntary counseling and testing, and Empowerment,' hopes to improve the traditional ABC model, which focused on 'Abstinence, Being faithful, and using Condoms,'" the news service adds.
Type 1 diabetes mellitus (T1DM) affects thousands of children, and causes high sugar levels because of low insulin production. In places with good access to medical care, blood glucose is first measured by capillary blood testing or continuous monitoring. Insulin is given as required by subcutaneous injection or insulin pump.
Kapa Biosystems and VWR International, LLC announced today that they have entered into a non-exclusive North American distribution agreement for Kapa Biosystems' line of next-generation PCR reagents.
› Verified 2 days ago
| Entity Name | Scl Health Medical Group - Grand Junction Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356765556 PECOS PAC ID: 3779707856 Enrollment ID: O20140611000363 |
News Archive
The disease course of COVID-19 is diverse, ranging from asymptomatic to fatal respiratory failure. Scientists have been working to uncover the immunological reasons behind this heterogeneity. A recent study on B cells, published on the preprint server medRxiv in April 2020, shows that extrafollicular B cells could be a marker of severe infection in the early stages, predicting the need for earlier immunomodulatory therapy.
Silence Therapeutics plc announces the issuance of United States patent 7,893,245, titled "Interfering RNA Molecules," by the United States Patent and Trademark Office.
"Twenty-eight years since the first HIV/AIDS case was reported in Kenya, organizations are proposing a new model to fight the epidemic," Sabahi reports. "The model, called 'SAVE,' an acronym for 'Safer practices, Access to treatment, Voluntary counseling and testing, and Empowerment,' hopes to improve the traditional ABC model, which focused on 'Abstinence, Being faithful, and using Condoms,'" the news service adds.
Type 1 diabetes mellitus (T1DM) affects thousands of children, and causes high sugar levels because of low insulin production. In places with good access to medical care, blood glucose is first measured by capillary blood testing or continuous monitoring. Insulin is given as required by subcutaneous injection or insulin pump.
Kapa Biosystems and VWR International, LLC announced today that they have entered into a non-exclusive North American distribution agreement for Kapa Biosystems' line of next-generation PCR reagents.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leslie Ann Gibson, CNM, FNP-BC Po Box 529, Olathe, CO 81425-0529 Ph: (970) 323-6141 | Leslie Ann Gibson, CNM, FNP-BC 1010 Rio Grande Ave, Montrose, CO 81401-4831 Ph: (970) 497-3333 |
News Archive
The disease course of COVID-19 is diverse, ranging from asymptomatic to fatal respiratory failure. Scientists have been working to uncover the immunological reasons behind this heterogeneity. A recent study on B cells, published on the preprint server medRxiv in April 2020, shows that extrafollicular B cells could be a marker of severe infection in the early stages, predicting the need for earlier immunomodulatory therapy.
Silence Therapeutics plc announces the issuance of United States patent 7,893,245, titled "Interfering RNA Molecules," by the United States Patent and Trademark Office.
"Twenty-eight years since the first HIV/AIDS case was reported in Kenya, organizations are proposing a new model to fight the epidemic," Sabahi reports. "The model, called 'SAVE,' an acronym for 'Safer practices, Access to treatment, Voluntary counseling and testing, and Empowerment,' hopes to improve the traditional ABC model, which focused on 'Abstinence, Being faithful, and using Condoms,'" the news service adds.
Type 1 diabetes mellitus (T1DM) affects thousands of children, and causes high sugar levels because of low insulin production. In places with good access to medical care, blood glucose is first measured by capillary blood testing or continuous monitoring. Insulin is given as required by subcutaneous injection or insulin pump.
Kapa Biosystems and VWR International, LLC announced today that they have entered into a non-exclusive North American distribution agreement for Kapa Biosystems' line of next-generation PCR reagents.
› Verified 2 days ago
Rebeccah L Fletcher, DNP, APN, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 715 S 3rd St, Montrose, CO 81401 Phone: 970-249-6737 Fax: 970-252-0112 | |
Theresa Frick, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 900 S 4th St, Montrose, CO 81401 Phone: 970-252-2542 Fax: 970-252-2544 | |
Dr. Amanda Leach, CNM, DNP Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 715 S 3rd St, Montrose, CO 81401 Phone: 970-249-6737 | |
Sabely Nichols, ARNP, CNM, WHNP-BC Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 715 S 3rd St, Montrose, CO 81401 Phone: 970-249-6737 Fax: 970-252-0112 | |
Mrs. Monica Rae Filippone, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 715 S 3rd St, Montrose, CO 81401 Phone: 970-249-6737 | |
Debra J Chapman, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 715 S 3rd St, Montrose, CO 81401 Phone: 970-249-6737 Fax: 970-252-0112 | |
Laura E. Pearson, MS, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 715 S 3rd St, Montrose, CO 81401 Phone: 970-249-6737 Fax: 970-252-0112 |